Pfizer ignores strike in Ireland as 900 employees’ pensions affected
February 7, 2019Business Services Ireland, Labour Court, Pfizer, cork, strike
US multinational Pfizer is going ahead with its decision to transfer 900 of its Irish employees into a new defined …
NICE joins forces with Canadian peer to offer scientific advice to the pharma industry
February 6, 2019Research and Development, Sales and Marketing CADTH, Canada, NICE, UK, pharma
NICE has announced a collaboration with its Canadian counterpart, the Canadian Agency for Drugs and Technology in Health (CADTH), with …
Sanofi’s Icaria combo extends progression-free survival in multiple myeloma at Phase 3
February 6, 2019Research and Development Icaria, Sanofi, multiple myeloma, pharma
Sanofi has continued to make progress in the development of Icaria (isatuximab), with the company announcing that the therapy met …
Genentech to develop ‘highly active cytokine’ with Xancor in deal worth $300m
February 6, 2019Research and Development Cancer, Genetech, IL-15 cytokine, Roche, Xancor, oncology
Roche’s Genentech unit has agreed to pay $120 million upfront as part of a research and licensing deal with California-based …
Takeda ordered to pay Bayer $155.19 million over patent infringement
February 6, 2019Research and Development Baxalta, Bayer, Nektar Therapeutics, Takeda, adynovate
A US court has ordered Takeda Pharmaceutical’s Baxalta unit to pay German firm Bayer AG $155.19 million for infringement of …
GSK buys Merck KGaA’s cancer immunotherapy for $4.2 billion
February 6, 2019Research and Development GSK, M7824, Merck, immunotherapy
British multinational GlaxoSmithKline has agreed to pay up to €3.7 billion ($4.2 billion) for the rights to Merck KGaA’s next …
Czech biotech SOTIO appoints experienced immune-oncology doc as new CMO
February 5, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Czech biotech SOTIO has announced the appointment of Dr Harald Fricke as the firm’s Chief Medical Officer (CMO). Dr Fricke, …
Former Ablynx exec joins Kiadis as Chief Scientific Officer
February 5, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, appointment, kiadis, pharma
Dutch/US firm Kiadis Pharma revealed that Dr Robert Friesen became its new Chief Science Officer (CSO) as January turned into …
Lilly’s Olumiant impresses in twin Phase 3 atopic dermatitis trials
February 5, 2019Manufacturing and Production, Research and Development Eli Lilly, Olumiant, atopic dermatitis, pharma
Eli Lilly has unveiled new Phase 3 data from two studies into the oral Janus kinase (JAK) inhibitor Olumiant (baricitinib). …
AstraZeneca scores accelerated approval in US and Europe for respiratory syncytial virus drug
February 5, 2019Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, EMA, FDA, MEDI8897, pharma, respiratory syncytial virus
It’s a double victory for AstraZeneca as the company announced its F monoclonal antibody MEDI8897 has been granted accelerated review …
More than 200 Xanax-related deaths in UK since 2015
February 5, 2019Manufacturing and Production Pfizer, UK, benzodiazepines, health, public health, xanax
There have been more than 200 deaths linked to misuse of the anti-anxiety drug Xanax in the UK since 2015. …
Reformulated OxyContin led to spike in Hepatitis C infections
February 5, 2019Manufacturing and Production OxyContin, USA, hepatitis C, heroin, infectious diseases, opioids
Efforts to create an “abuse deterrent” OxyContin pill inadvertently led to an increase in the number of Hepatitis C infections, …
Sanders calls on Catalyst pharma to justify $375,000 price tag for rare disease drug which was once free
February 5, 2019Manufacturing and Production Catalyst Pharmaceuticals, Jacobus Pharmaceuticals, Sanders, USA, pharma, pricing
Shares in Catalyst Pharmaceuticals plummeted Monday, after US Senator Bernie Sanders sent the firm a letter asking them to justify …
Alexander Hardy returns to Genentech as new CEO
February 4, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genentech, appointment, pharma
Genetech, the biotech subsidiary of Swiss firm Roche, has named its new CEO, revealing that Alexander Hardy will be returning …
Positive CHMP recommendation for Sanofi’s atherosclerotic CVD drug Praluent
February 4, 2019Sales and Marketing Europe, atherosclerotic cardiovascular disease, cvd, pharma, praluent
It has been announced that Sanofi’s Praluent (alirocumab) has been awarded a positive recommendation from the European Medicines Agency’s Committee …
Counterfeit drugs – countering the lies
February 4, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Counterfeit drugs, IP, counterfeit medicines, falsified medicines, intellectual property, law, legal, patent
As the Falsified Medicines Directive comes into effect in February 2019, Louis Goss fact checks ‘common sense’ claims on counterfeit …
100,000 extra GP appointments to be made available in Gloucestershire as part of NHS Long Term Plan
February 4, 2019Sales and Marketing GP, Gloucestershire, NHS, UK, britain, primare care
GP practices in Gloucestershire are set to offer 100,000 more appointments for patients in the coming year. The initiative comes …
FDA knocks back Alkermes’ opioid-based depression therapy over lack of evidence
February 4, 2019Sales and Marketing Alkermes, FDA, major depressive disorder, pharma, rejection
Alkermes experimental opioid-based depression therapy ALKS 5461 has been rejected by the FDA, it has emerged, in the adjunctive treatment …
Cambridgeshire and Peterborough NHS Foundation Trust launches mental health clinical trials
February 4, 2019Sales and Marketing UK, clinical trials, clozapine, mental health, schizophrenia
The Cambridgeshire and Peterborough NHS Foundation Trust’s Windsor Research Unit is offering patients the chance to participate in clinical trials …
Obesity-related cancers on the rise amongst millennials
February 4, 2019Sales and Marketing Cancer, obesity, oncology, young people
Cancers related to obesity are on the rise in young adults, according to findings from the American Cancer Society, published …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
